When to Consider Dual Immunotherapy in NSCLC #LungCancer #NSCLC
0:35
When to Consider Dual Immunotherapy in NSCLC #LungCancer #NSCLC
111 views3 weeks ago
YouTubeTargeted Onc
Taletrectinib in ROS1-Positive Non-Small Cell Lung Cancer
0:39
Taletrectinib in ROS1-Positive Non-Small Cell Lung Cancer
193 views1 month ago
YouTubeCheckRare
Key clinical takeaways: HER2-mutant NSCLC highlights from ESMO 2026
1:30
Key clinical takeaways: HER2-mutant NSCLC highlights from ESMO 2026
465 views2 weeks ago
YouTubeCOR2ED The Heart of Medical Education
FDA Moves Hyrnuo (sevabertinib) Into First-Line Therapy for HER2-Positive NSCLC
0:46
FDA Moves Hyrnuo (sevabertinib) Into First-Line Therapy for HER2-Positive NSCLC
1.2K views2 months ago
YouTubeGO2 for Lung Cancer
Break the Myths. Understand the Facts. Fight Lung Cancer.
0:56
Break the Myths. Understand the Facts. Fight Lung Cancer.
1 month ago
YouTubeDr Arvind Reddy Muthirevula
Treatment Algorithm: Metastatic NSCLC W/O Targeted Mutations with Dr. Christine Garcia
1:20
Treatment Algorithm: Metastatic NSCLC W/O Targeted Mutations with Dr. Christine Garcia
492 views6 months ago
YouTubeOncBrothers: Practice-Changing Cancer Discussions
Many patients with KRAS G12C–mutant NSCLC may never advance to 2L therapy
0:20
Many patients with KRAS G12C–mutant NSCLC may never advance to 2L therapy
853.2K views4 months ago
YouTubeLilly Medical
0:20
What drives KRAS G12C–mutant NSCLC response to immunotherapy?
600.2K views3 months ago
YouTubeLilly Medical
2:09
Osimertinib plus Chemotherapy in EGFR-Mutated NSCLC (FLAURA2)
2.3K views4 months ago
YouTubeNEJM Group
1:23
EGFR Inhibitors for NSCLC
187 views4 months ago
YouTubeCancerCare
0:51
FDA Approval Jideytro (zidesamtinib) | Lung Cancer Awareness | Lung Cancer Treatment Update
131 views3 months ago
YouTubeGO2 for Lung Cancer
0:15
Mind Over Matter | Guided Skills-Based Program for People Impacted by Lung Cancer
2 views1 month ago
YouTubeGO2 for Lung Cancer
0:32
KRAS G12C Differs from Other Variants
441.8K views2 months ago
YouTubeLilly Medical
Here are the symptoms I experienced leading up to my NSC lung cancer diagnosis as an otherwise healthy, young, and active woman. ##nsclc##lungcancer##cancerwarrior##lungcancerstage3##nonsmallcelllungcancer##lungcancerawareness##onelung##cancer##cancerpatient##cancersurvivors##lungcancerstage4##breatheforward
1.1M viewsAug 8, 2023
TikTokonelunglady
4:27
DAY 9 and I don’t have any words for the pain i’m feeling. My mam doesn’t deserve any of this. #anticipatorygrief #nsclc #stage4lungcancer #grief #terminallyill
58.4K viewsOct 29, 2025
TikToktaramariad
0:12
What’s going on is RIGHT!!! It’s officially November 1st, marking the start of #LungCancerAwarenessMonth, and I couldn’t miss the chance to spotlight lung cancer in people who’ve never smoked. Did you know that up to 1 in 5 lung cancer cases occur in individuals with NO smoking history? A recent JAMA review found: ▫️Most are adenocarcinomas (60–80%) ▫️Targetable mutations like EGFR and ALK are far more common ▫️Median survival for those with advanced NSCLC who receive targeted therapy can exceed
47.6K viewsNov 1, 2025
TikToklungoncdoc
0:06
Lung Cancer: It Can Affect Anyone, Not Just Smokers
1.5K views3 weeks ago
TikTokalkpositiveuk
0:26
El cáncer de pulmón no es una enfermedad uniforme. Se clasifica principalmente en: - Cáncer de pulmón de células no pequeñas (NSCLC): representa el 85% de los casos. — Cáncer de células pequeñas (SCLC): menos frecuente, pero más agresivo. Esta distinción influye directamente en el abordaje terapéutico y en el pronóstico. #cáncer #cáncerdepulmón #pulmones #salud #oncologo
95.2K viewsAug 16, 2025
TikTokdrjorgealatorre
1:23
#breathlessnesssucks #nsclc #cancerfighter #lungcancer
50.4K viewsNov 8, 2023
TikTokmolly.moo723
0:58
Early detection is so important, yet so elusive for many patients. There has to be a better way. #lungcancer #alkpositive #livingwithlungcancer #nsclc #chemotherapy #metastasis
56.5K viewsDec 12, 2022
TikTokrosenylund722
See more
Static thumbnail place holder